Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)

British Journal of Clinical Pharmacology

Volumn 71, Issue 3, 2011, Pages 313-315

  Ritter, J M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TELMISARTAN; VALSARTAN;

BLOOD PRESSURE MEASUREMENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; META ANALYSIS (TOPIC); NONHUMAN; NOTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW (TOPIC);

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 79251628080     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03918.x     Document Type: Note

References (16)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J for the randomized aldactone evaluation study investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 1999; 341: 709-17
2. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-21
3. Schrier RW. Aldosterone 'escape' vs 'breakthrough' Nature Reviews Nephrology 2010; 6: 61
4. Menard J, Guyenne TT, Chatelier G, Kleinbloesem CH, Bernadet P. Renin release regulation during acute renin inhibition in normal volunteers. Hypertension 1991; 18: 257-65
5. Van den Meiracker AH, Man in't Veld AJ, Admiraal PJ. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992; 10: 803-12
6. Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007; 217: 141-54
7. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol 1989; 412: 543-55
8. Menard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight and renin in spontaneously hypertensive rats. Circulation 1997; 96: 3072-8
9. Messerli FH. The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point. Journal of the American College of Cardiology doi: 10.1016/j.jacc.2008.10.036
10. Doulton TW, He FJ, MacGregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 2005; 45: 880-6
11. MacGregor GA, Markandu ND, Smith SJ, Sagnella GA. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol or nifedipine. J Cardiovasc Pharmacol 1985; 7Suppl11: S82-7
12. Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008; 148: 30-48
13. The ONTARGET investigators. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59
14. Pfeffer MA, McMurray JJV, Velasquez EJ, Rouleau J-L, Kober L, Maggioni AP etal. The valsartan in acute myocardial infarction trial I. Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1839-1906
15. Wan AH Wan Md Adnam, Zarahan NL, Bennett K, Wall KA. Trends in co-prescription of angiotensin converting enzyme inhibitors and angiotensin blockers in Ireland. Br J Clin Pharmacol 2011; 71: 458-66
16. Ritter JM. Research and education (editors' view). Br J Clin Pharmacol 2008; 66: 1-3